Clinical Trial

Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol

Study acronym: ATLANTIC
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess improvements in visual performance and patient outcomes in wearing new spectacle lenses in general population. The two spectacle lenses will be compared after two weeks of wearing. The aims are: * to evaluate the visual superiority, and quality-of-life implications of Essilor® AVA™ spectacle lenses prescribed after a new subjective refraction protocol named AVA™ protocol. * to understand the benefits of using a high accuracy instrument and testing sequence over the standard testing sequence in determining a glasses prescription, as well as the overall subjective performance of the resulting glasses.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-09; most recent amendment 2026-06-08.
Status change: Recruiting → Completed 2026-06-08
Status change: Not Yet Recruiting → Recruiting 2025-10-02
Trial Details
NCT Number NCT07168564
Lead Sponsor Essilor International
Conditions Ametropia, Refractive Error
Enrollment 120 participants
Start Date 2025-09-22
Primary Completion 2026-05-28 (estimated)
Study Completion 2026-05-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-09